1
|
Peter S, Aderibigbe BA. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity. Molecules 2019; 24:molecules24193604. [PMID: 31591298 PMCID: PMC6804011 DOI: 10.3390/molecules24193604] [Citation(s) in RCA: 81] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 08/20/2019] [Accepted: 08/21/2019] [Indexed: 12/19/2022] Open
Abstract
Malaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antimalarial and anticancer. Drugs such as ferroquine were developed from ferrocene and chloroquine. It was tested in the 1990s as an antimalarial and is still an effective antimalarial. Many researchers have reported ferrocene compounds as potent compounds useful as anticancer and antimalarial agents when hybridized with other pharmaceutical scaffolds. This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.
Collapse
Affiliation(s)
- Sijongesonke Peter
- Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South Africa.
| | - Blessing Atim Aderibigbe
- Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South Africa.
| |
Collapse
|
2
|
Dalzon B, Bons J, Diemer H, Collin-Faure V, Marie-Desvergne C, Dubosson M, Cianferani S, Carapito C, Rabilloud T. A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes. Proteomes 2019; 7:26. [PMID: 31238524 PMCID: PMC6630412 DOI: 10.3390/proteomes7020026] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 06/18/2019] [Accepted: 06/21/2019] [Indexed: 02/07/2023] Open
Abstract
Metal-containing drugs have long been used in anticancer therapies. The mechansims of action of platinum-based drugs are now well-understood, which cannot be said of drugs containing other metals, such as gold or copper. To gain further insights into such mechanisms, we used a classical proteomic approach based on two-dimensional elelctrophoresis to investigate the mechanisms of action of a hydroxyquinoline-copper complex, which shows promising anticancer activities, using the leukemic cell line RAW264.7 as the biological target. Pathway analysis of the modulated proteins highlighted changes in the ubiquitin/proteasome pathway, the mitochondrion, the cell adhesion-cytoskeleton pathway, and carbon metabolism or oxido-reduction. In line with these prteomic-derived hypotheses, targeted validation experiments showed that the hydroxyquinoline-copper complex induces a massive reduction in free glutathione and a strong alteration in the actin cytoskeleton, suggesting a multi-target action of the hydroxyquinoline-copper complex on cancer cells.
Collapse
Affiliation(s)
- Bastien Dalzon
- Chemistry and Biology of Metals, Univ. Grenoble Alpes, CNRS UMR5249, CEA, IRIG,CBM, F-38054 Grenoble, France.
| | - Joanna Bons
- Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 Strasbourg, France.
| | - Hélène Diemer
- Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 Strasbourg, France.
| | - Véronique Collin-Faure
- Chemistry and Biology of Metals, Univ. Grenoble Alpes, CNRS UMR5249, CEA, IRIG,CBM, F-38054 Grenoble, France.
| | - Caroline Marie-Desvergne
- Nanosafety Platform, Medical Biology Laboratory (LBM), Univ. Grenoble-Alpes, CEA, 17 rue des Martyrs, F-38054 Grenoble, France.
| | - Muriel Dubosson
- Nanosafety Platform, Medical Biology Laboratory (LBM), Univ. Grenoble-Alpes, CEA, 17 rue des Martyrs, F-38054 Grenoble, France.
| | - Sarah Cianferani
- Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 Strasbourg, France.
| | - Christine Carapito
- Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Université de Strasbourg, CNRS, IPHC UMR 7178, 67000 Strasbourg, France.
| | - Thierry Rabilloud
- Chemistry and Biology of Metals, Univ. Grenoble Alpes, CNRS UMR5249, CEA, IRIG,CBM, F-38054 Grenoble, France.
| |
Collapse
|
3
|
Khan SA, Asiri AM, Al-Ghamdi NSM, Zayed ME, Sharma K, Parveen H. Optical properties of novel environmentally benign biologically active ferrocenyl substituted chromophores: A detailed insight via experimental and theoretical approach. J Mol Struct 2017. [DOI: 10.1016/j.molstruc.2017.03.044] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
4
|
Neidlinger A, Kienz T, Heinze K. Spin Trapping of Carbon-Centered Ferrocenyl Radicals with Nitrosobenzene. Organometallics 2015. [DOI: 10.1021/acs.organomet.5b00778] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Andreas Neidlinger
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| | - Torben Kienz
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| | - Katja Heinze
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| |
Collapse
|
5
|
Adams M, de Kock C, Smith PJ, Land KM, Liu N, Hopper M, Hsiao A, Burgoyne AR, Stringer T, Meyer M, Wiesner L, Chibale K, Smith GS. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes. Dalton Trans 2015; 44:2456-68. [PMID: 25559246 DOI: 10.1039/c4dt03234a] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
A series of ferrocenyl- and aryl-functionalised organosilane thiosemicarbazone compounds was obtained via a nucleophilic substitution reaction with an amine-terminated organosilane. The thiosemicarbazone (TSC) ligands were further reacted with either a ruthenium dimer [(η(6-i)PrC6H4Me)Ru(μ-Cl)Cl]2 or a rhodium dimer [(Cp*)Rh(μ-Cl)Cl]2 to yield a series of cationic mono- and binuclear complexes. The thiosemicarbazone ligands, as well as their metal complexes, were characterised using NMR and IR spectroscopy, and mass spectrometry. The molecular structure of the binuclear ruthenium(ii) complex was determined by single-crystal X-ray diffraction analysis. The thiosemicarbazones and their complexes were evaluated for their in vitro antiplasmodial activities against the chloroquine-sensitive (NF54) and chloroquine-resistant (Dd2) Plasmodium falciparum strains, displaying activities in the low micromolar range. Selected compounds were screened for potential β-haematin inhibition activity, and it was found that two Rh(iii) complexes exhibited moderate to good inhibition. Furthermore, the compounds were screened for their antitrichomonal activities against the G3 Trichomonas vaginalis strain, revealing a higher percentage of growth inhibition for the ruthenium and rhodium complexes over their corresponding ligand.
Collapse
Affiliation(s)
- Muneebah Adams
- Department of Chemistry, University of Cape Town, Rondebosch 7701, Cape Town, South Africa.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Babin VN, Belousov YA, Borisov VI, Gumenyuk VV, Nekrasov YS, Ostrovskaya LA, Sviridova IK, Sergeeva NS, Simenel AA, Snegur LV. Ferrocenes as potential anticancer drugs. Facts and hypotheses. Russ Chem Bull 2015. [DOI: 10.1007/s11172-014-0756-7] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
7
|
Abstract
The mechanisms of action of ferrocifens depend on several features: chemical structures, used concentrations, nature of cancer cells.
Collapse
Affiliation(s)
- Gérard Jaouen
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| | - Anne Vessières
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| | - Siden Top
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| |
Collapse
|
8
|
Ferrocifen derivatives that induce senescence in cancer cells: selected examples. J Inorg Biochem 2014; 141:144-151. [DOI: 10.1016/j.jinorgbio.2014.08.015] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Revised: 08/28/2014] [Accepted: 08/29/2014] [Indexed: 01/01/2023]
|
9
|
Lu C, Heldt JM, Guille-Collignon M, Lemaître F, Jaouen G, Vessières A, Amatore C. Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens. ChemMedChem 2014; 9:1286-93. [PMID: 24803138 DOI: 10.1002/cmdc.201402016] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2014] [Indexed: 11/10/2022]
Abstract
Ferrocifens are an original class of ferrocifen-type breast cancer drugs. They possess anti-proliferative effects due to the association of the ferrocene moiety and the tamoxifen skeleton. In this work, fluorescence measurements indicated the production of reactive oxygen species (ROS) if hormone-dependent or -independent breast cancer cells were incubated with three hit ferrocifen compounds. Additionally, amperometry at ultramicroelectrodes was carried out to identify and quantify ROS and reactive nitrogen species (RNS) under stress conditions. Videomicroscopy was used to optimize the conditions employed for electrochemical investigations. Amperometry was then performed on two cell lines pre-incubated with each of the three ferrocifens. Interestingly, these results demonstrate that the presence of an aminoalkyl chain in the ferrocifen structure may confer a unique behavior toward both cell lines, in comparison with the two other compounds that lack this feature.
Collapse
Affiliation(s)
- Cong Lu
- Ecole Normale Supérieure-PSL Research University, Département de Chimie, 24 rue Lhomond, 75005 Paris (France), Fax: (+33) 1-4432-3863; Sorbonne Universités, UPMC Univ. Paris 06, PASTEUR, 75005, Paris (France); CNRS, UMR 8640 PASTEUR, 75005, Paris (France)
| | | | | | | | | | | | | |
Collapse
|
10
|
Zanellato I, Bonarrigo I, Ravera M, Gabano E, Gust R, Osella D. The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells. Metallomics 2013; 5:1604-13. [PMID: 24057048 DOI: 10.1039/c3mt00117b] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The antiproliferative activity of the aspirin derivative [2-acetoxy-(2-propynyl)benzoate]hexacarbonyldicobalt (Co-ASS) and its analogue hexacarbonyl[μ-(2-ethylphenyl)methanol]dicobalt (Co-EPM) was investigated on malignant pleural mesothelioma (MPM) cell lines, having an epithelioid or a sarcomatoid phenotype. In sarcomatoid cell lines Co-ASS was more potent than Co-EPM and the prototypal metallo-drug cisplatin, and induced cell death through the intrinsic apoptotic pathway, associated with a strong NF-κB inhibition. In contrast, both Co-ASS and Co-EPM showed only a modest cytostatic activity against epithelioid MPM cells. Co-EPM induced an increase of senescent cells, while Co-ASS did not; the different outcomes were traced back to the organic (aspirin-like) portion of the molecule. Both Co-EPM and Co-ASS significantly reduced reactive oxygen/nitrogen species (ROS/RNS), and in turn nitrites, suggesting that the hexacarbonyldicobalt moiety may deliver CO within the cell, acting as a CO-releasing molecule (CO-RM). In perspective, Co-ASS would be better considered as a CO-NSAID agent (a CO-releasing molecule retaining the NSAID properties similar to NO- and H2S-NSAIDs) than as an antitumor drug candidate.
Collapse
Affiliation(s)
- Ilaria Zanellato
- Dipartimento di Scienze e Innovazione Tecnologica (DiSIT), Sezione Ambiente-Vita, Università del Piemonte Orientale "A. Avogadro", Viale T. Michel 11, 15121 Alessandria, Italy.
| | | | | | | | | | | |
Collapse
|
11
|
D'Antona N, Morrone R, Nicolosi G, Pedotti S. Novel enzymatic recognition of the ferrocene framework: nitrile hydratase/amidase catalyzed cascade biotransformations. RSC Adv 2013. [DOI: 10.1039/c3ra22737e] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
12
|
Zanellato I, Bonarrigo I, Gabano E, Ravera M, Margiotta N, Betta PG, Osella D. Metallo-drugs in the treatment of malignant pleural mesothelioma. Inorganica Chim Acta 2012. [DOI: 10.1016/j.ica.2012.06.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
13
|
Messina P, Labbé E, Buriez O, Hillard EA, Vessières A, Hamels D, Top S, Jaouen G, Frapart YM, Mansuy D, Amatore C. Deciphering the activation sequence of ferrociphenol anticancer drug candidates. Chemistry 2012; 18:6581-7. [PMID: 22492462 DOI: 10.1002/chem.201103378] [Citation(s) in RCA: 67] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2011] [Indexed: 11/06/2022]
Abstract
The complete oxidation sequence of a model for ferrociphenols, a new class of anticancer drug candidate, is reported. Cyclic voltammetry was used to monitor the formation of oxidation intermediates on different timescales, thereby allowing the electrochemical characterization of both the short-lived and stable species obtained from the successive electron-transfer and deprotonation steps. The electrochemical preparation of the ferrocenium intermediate enabled a stepwise voltammetric determination of the stable oxidation compounds obtained upon addition of a base as well as the electron stoichiometry observed for the overall oxidation process. A mechanism has been established from the electrochemical data, which involves a base-promoted intramolecular electron transfer between the phenol and the ferrocenium cation. The resulting species is further oxidized then deprotonated to yield a stable quinone methide. To further characterize the transient species successively formed during the two-electron oxidation of the ferrociphenol to its quinone methide, EPR was used to monitor the fate of the paramagnetic species generated upon addition of imidazole to the electrogenerated ferrocenium. The study revealed the passage from an iron-centered to a carbon-centered radical, which is then oxidized to yield the quinone methide, namely, the species that interacts with proteins and so forth under biological conditions.
Collapse
Affiliation(s)
- Pierluca Messina
- UMR CNRS 8640 PASTEUR Ecole Normale Supérieure, Département de Chimie & Université Pierre et Marie Curie, 24 rue Lhomond, 75231 Paris Cedex 05, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Zhao F, Zhao C, Liu ZQ. Synthesis of hydroxyferrocifen and its abilities to protect DNA and to scavenge radicals. J Biol Inorg Chem 2011; 16:1169-76. [DOI: 10.1007/s00775-011-0805-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2011] [Accepted: 06/11/2011] [Indexed: 11/30/2022]
|
15
|
Margiotta N, Ostuni R, Piccinonna S, Natile G, Zanellato I, Boidi CD, Bonarrigo I, Osella D. Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis. J Inorg Biochem 2011; 105:548-57. [DOI: 10.1016/j.jinorgbio.2010.12.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2010] [Revised: 12/23/2010] [Accepted: 12/23/2010] [Indexed: 01/05/2023]
|
16
|
Bendrath F, Villinger A, Langer P. Regioselective synthesis of functionalized ferrocenylphenols based on cyclocondensation reactions of free and masked 1,3-dicarbonyl dianions. J Organomet Chem 2011. [DOI: 10.1016/j.jorganchem.2011.01.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Görmen M, Pigeon P, Top S, Hillard EA, Huché M, Hartinger CG, de Montigny F, Plamont MA, Vessières A, Jaouen G. Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells. ChemMedChem 2010; 5:2039-50. [DOI: 10.1002/cmdc.201000286] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
18
|
Plazuk D, Top S, Vessières A, Plamont MA, Huché M, Zakrzewski J, Makal A, Woźniak K, Jaouen G. Organometallic cyclic polyphenols derived from 1,2-(α-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells. Dalton Trans 2010; 39:7444-50. [DOI: 10.1039/c0dt00169d] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
19
|
Hillard EA, Vessières A, Jaouen G. Ferrocene Functionalized Endocrine Modulators as Anticancer Agents. TOP ORGANOMETAL CHEM 2010. [DOI: 10.1007/978-3-642-13185-1_4] [Citation(s) in RCA: 104] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|